Indivior Pharmaceuticals (INDV) Inventory (2021 - 2026)

Indivior Pharmaceuticals has reported Inventory for 6 years, with the latest figure at $150.0 million in Q2 2026.

• On a quarterly basis, Inventory rose 0.67% year-over-year to $150.0 million in Q2 2026; TTM through Jun 2026 was $150.0 million, a 0.67% increase from a year earlier, with the FY2025 full-year figure at $153.0 million, down 8.38% from the prior year.
• Inventory was $150.0 million for Q2 2026 at Indivior Pharmaceuticals, down from $152.0 million in the prior quarter.
• The five-year high for Inventory was $167.0 million in Q4 2024, with the low at $114.0 million in Q4 2022.
• Average Inventory over 5 years is $147.7 million, with a median of $152.0 million recorded in 2026.
• The sharpest annual moves came in 2024 and 2025: Inventory soared 32.54% in 2024, then dropped 8.38% in 2025.
• Over 5 years, Inventory stood at $114.0 million in 2022, then grew by 10.53% to $126.0 million in 2023, then jumped by 32.54% to $167.0 million in 2024, then decreased by 8.38% to $153.0 million in 2025, then fell by 1.96% to $150.0 million in 2026.
• The last three Inventory figures came in at $150.0 million (Q2 2026), $152.0 million (Q1 2026), and $153.0 million (Q4 2025), per Business Quant data.